Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Brescia
Clinical trial register · Italy

Clinical Trials in Brescia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 138 Naples 80 Roma 72 Florence 57 Padova 56
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca27 Fondazione Italiana Linfomi - ETS25 Novartis Pharmaceuticals21 Hoffmann-La Roche18 Merck Sharp & Dohme LLC16 Clear sponsor filter
Site location
Milan138 Naples80 Roma72 Florence57 Padova56
All 111 locations
Target enrolment
to

Trials with a site in Brescia

27 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
AstraZeneca
Phase 3
1,072
Brescia, Cona, Florence, Milan, Roma
2026-08-31
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Ancona, Bergamo, Brescia, Milan, Pavia, Perugia, Riccione, Salerno
2026-08-24
Recruiting
AstraZeneca
Phase 3
245
Brescia, Catania, Ferrara, Florence, Milan, Padova, Pisa, Roma
2026-04-13
Recruiting
AstraZeneca
Phase 2
43
Brescia, Rozzano, Torino, Verona
2026-03-28
Recruiting
AstraZeneca
Observational
218
Monserrato, Cona, San Giovanni Rotondo, Rozzano, Ancona, Bari, Brescia, Florence
2025-12-31
Recruiting
AstraZeneca
Phase 3
1,100
Brescia, Catania, Florence, Lecco, Milan, Naples, Parma, Pisa
2025-12-29
Recruiting
AstraZeneca
Phase 3
250
Bologna, Brescia, Florence, Milan, Torino
2025-08-07
Active, closed
AstraZeneca
Observational
315
Cittadella (PD), Montebelluna (TV), Aosta, Avellino, Bari, Bergamo, Brescia, Cagliari
2025-06-25
Recruiting
AstraZeneca
Phase 3
15,100
Altamura, Arzignano, Bergamo, Bologna, Brescia, Caserta, Catania, Cona
2025-06-04
Recruiting
AstraZeneca
Phase 3
400
Bari, Bergamo, Brescia, Cagliari, Catanzaro, Genoa, Milan, Modena
2025-03-28
Recruiting
AstraZeneca
Phase 3
11,300
Alessandria, Bari, Bergamo, Brescia, Chiavari, Cona, Foggia, Milan
2025-03-14
Active, closed
AstraZeneca
Phase 3
339
Brescia, Cona, Florence, Milan, Naples, Reggio Emilia, Roma, Rome
2024-06-29
Recruiting
AstraZeneca
Phase 3
3,850
Acquaviva delle Fonti, Bari, Bergamo, Brescia, Catania, Catanzaro, Cona, Cortona
2024-04-12
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Naples, Rome, Brescia, Milan, Rozzano, Turin, Monserrato, Pisa
2023-12-20
Active, closed
AstraZeneca
Phase 3
314
Ancona, Brescia, Cona, Milan, Padova, Roma
2023-11-08
Active, closed
AstraZeneca
Phase 2
188
Avellino, Brescia, Lecce, Milan, Naples, Palermo, Peschiera del Garda, Reggio Emilia
2023-03-06
Active, closed
AstraZeneca
Observational
551
Naples, Cona, Udine, Rome, Brescia, Milan, Turin, Cagliari
2023-02-27
Recruiting
AstraZeneca
Phase 3
3,527
Arezzo, Brescia, Naples, Roma, Rozzano, Torino
2022-12-13
Active, closed
AstraZeneca
Phase 3
1,174
Bologna, Brescia, Florence, Genova, Livorno, Meldola, Messina, Milan
2022-11-28
Recruiting
AstraZeneca
Phase 2
630
Aviano, Brescia, Catanzaro, Florence, Genova, Meldola, Milan, Monza
2022-04-14
Active, closed
AstraZeneca
Phase 3
1,051
Brescia, Florence, Lucca, Meldola, Orbassano, Parma, Pavia, Roma
2022-02-07
Active, closed
AstraZeneca
Phase 3
370
Brescia, Candiolo, Florence, Milan, Modena, Naples, Padova
2020-10-02
Active, closed
AstraZeneca
Phase 3
185
Ancona, Bologna, Brescia, Candiolo, Catania, Lecce, Lecco, Milan
2020-08-04
Active, closed
AstraZeneca
Phase 3
1,407
Brescia, Lecce, Lecco, Milan, Mirano, Naples, Reggio Calabria, Reggio Emilia
2019-01-04
Active, closed
AstraZeneca
Phase 3
724
Arezzo, Brescia, Milan, Pisa
2018-11-30
Active, closed
AstraZeneca
Phase 3
730
Brescia, Milan, Orbassano, Parma, Roma, Rozzano, Terni
2018-09-27
Active, closed
AstraZeneca
Phase 2
273
Ancona, Bologna, Brescia, Cona, Genova, Lecco, Meldola, Messina
2018-03-07
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/brescia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Brescia that also match the filters currently applied.

How many clinical trials are recruiting in Brescia?

14 of the 27 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Brescia), 27 studies
PhaseStudiesRecruitingShare
Phase 3191070.4%
Observational4214.8%
Phase 24214.8%

Most active sponsors

Lead sponsors with the most studies (Brescia)
Lead sponsorStudiesRecruiting
AstraZeneca2714
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.